SEATTLE, Nov. 08, 2017 -- Expeditors International of Washington, Inc. (NASDAQ: EXPD), today announced that on November 7, 2017, its Board of Directors declared a semi-annual cash dividend of $0.42 per share, payable on December 15, 2017 to shareholders of record as of December 1, 2017.
Expeditors is a global logistics company headquartered in Seattle, Washington. The Company employs trained professionals in 177 district offices and numerous branch locations located on six continents linked into a seamless worldwide network through an integrated information management system. Services include the consolidation or forwarding of air and ocean freight, customs brokerage, vendor consolidation, cargo insurance, time-definite transportation, order management, warehousing and distribution and customized logistics solutions.
| CONTACTS: | |||
| Jeffrey S. Musser | Bradley S. Powell | Geoffrey Buscher | |
| President and Chief Executive Officer | Senior Vice President and Chief Financial Officer | Director - Investor Relations | |
| (206) 674-3433 | (206) 674-3412 | (206) 892-4510 | |


Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
How Marco Pharma International Preserves German Homeopathic Traditions in America
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 



